← Back to Search

Opioid Analgesic

Intrathecal Morphine Injection for Lower Back Pain in Spine Deformity Surgery

Phase 4
Recruiting
Led By Andrew Chung, DO
Research Sponsored by Sonoran Spine Research and Education Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-year follow up
Awards & highlights

Study Summary

This trial will compare the effects of a pain management technique involving injecting morphine into the spinal cord versus traditional pain management strategies on post-operative recovery for patients who have undergone surgery to correct deformities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-year follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-year follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain and Outcome Assessment
Secondary outcome measures
Pain medications

Trial Design

2Treatment groups
Active Control
Group I: Control GroupActive Control1 Intervention
Patients in this group will receive standard post-operative pain medications but will not receive intrathecal morphine
Group II: Study GroupActive Control1 Intervention
Patients in this group will receive intrathecal morphine in addition to standard post-operative pain medications

Find a Location

Who is running the clinical trial?

Sonoran Spine Research and Education FoundationLead Sponsor
Andrew Chung, DOPrincipal InvestigatorSonoran Spine Research and Education Foundation
Michael S Chang, MDPrincipal InvestigatorSonoran Spine Research and Education Foundation

Media Library

Intrathecal Morphine Injection (Opioid Analgesic) Clinical Trial Eligibility Overview. Trial Name: NCT05092828 — Phase 4
Lower Back Pain Research Study Groups: Control Group, Study Group
Lower Back Pain Clinical Trial 2023: Intrathecal Morphine Injection Highlights & Side Effects. Trial Name: NCT05092828 — Phase 4
Intrathecal Morphine Injection (Opioid Analgesic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05092828 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA given its stamp of approval to Control Group?

"As this is a Phase 4 trial, and therefore approved for use, the safety of Control Group was rated 3 on our team's scale."

Answered by AI

Has there been any exploration into the efficacy of Control Group in other research projects?

"At present, 54 medical trials are being conducted on Control Group with 15 of them in the advanced Phase 3. Boston is hosting the majority of these experiments while a total of 131 centres across the US are working on Control Group research."

Answered by AI

Are there any available spots for participants in this clinical trial?

"Indeed, clinicaltrials.gov indicates that this trial is presently looking for participants; the first posting was on December 1st 2021 and the most recent update occurred on May 9th 2022."

Answered by AI

What is the current enrollment rate for this experiment?

"Affirmative. According to clinicaltrials.gov, this trial is currently calling for applicants which was initially posted on December 1st 2021 and updated as recently as May 9th 2022. The research intends to enrol 40 participants across two different medical sites."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
What site did they apply to?
Sonoran Spine
What portion of applicants met pre-screening criteria?
Met criteria
~12 spots leftby Apr 2025